3,404
Views
27
CrossRef citations to date
0
Altmetric
Express Communication

An in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin α

ORCID Icon, , , , , , , , & show all
Pages 2851-2864 | Received 02 Jun 2020, Accepted 19 Oct 2020, Published online: 02 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Eric Duverger, Guillaume Herlem & Fabien Picaud. (2023) Nanovectorization of Ivermectin to avoid overdose of drugs. Journal of Biomolecular Structure and Dynamics 41:10, pages 4272-4285.
Read now
Sanjay Kumar Dey, Manisha Saini, Chetna Dhembla, Shruti Bhatt, A. Sai Rajesh, Varnita Anand, Hirendra Kumar Das & Suman Kundu. (2022) Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:24, pages 14067-14083.
Read now
Chandan Sarkar, Mohnad Abdalla, Milon Mondal, Abul Bashar Ripon Khalipha & Nasir Ali. (2022) Ebselen suitably interacts with the potential SARS-CoV-2 targets: an in-silico approach. Journal of Biomolecular Structure and Dynamics 40:22, pages 12286-12301.
Read now
Martiniano Bello. (2022) Elucidation of the inhibitory activity of ivermectin with host nuclear importin α and several SARS-CoV-2 targets. Journal of Biomolecular Structure and Dynamics 40:18, pages 8375-8383.
Read now
Armin Zarei, Ali Ramazani, Saeed Pourmand, Ahmad Sattari, Aram Rezaei & Sajad Moradi. (2022) In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds. Natural Product Research 36:16, pages 4254-4260.
Read now

Articles from other publishers (21)

N. Anis Ahamed & Ibrahim A. Arif. (2023) Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies. Saudi Journal of Biological Sciences 30:12, pages 103845.
Crossref
Alejandra García-Aguilar, Rebeca Campi-Caballero, Giovani Visoso-Carvajal, José Rubén García-Sánchez, José Correa-Basurto, Jazmín García-Machorro & Judith Espinosa-Raya. (2023) In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction. International Journal of Molecular Sciences 24:22, pages 16392.
Crossref
Liliana Betancur-Galvis, Orlando José Jimenez-Jarava, Fatima Rivas, William E. Mendoza-Hernández & Miguel A. González-Cardenete. (2023) Synergistic In Vitro Antiviral Effect of Combinations of Ivermectin, Essential Oils, and 18-(Phthalimid-2-yl)ferruginol against Arboviruses and Herpesvirus. Pharmaceuticals 16:11, pages 1602.
Crossref
Mudasir Nabi Peerzada & Saurabh Verma. 2023. Chemistry and Biological Activities of Ivermectin. Chemistry and Biological Activities of Ivermectin 141 161 .
Muchtaridi MuchtaridiAdham Rizki AnandaFajri RaihanIndah Permata RendiCecep SuhandiDriyanti Rahayu. (2023) A Narrative Review: Molecular Docking Simulation of Antiviral Drugs as Anti-COVID-19 Candidates. Research Journal of Pharmacy and Technology, pages 3031-3037.
Crossref
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B. Patel, Nikita Sharma & Zhe-Sheng Chen. (2022) Recent review of COVID-19 management: diagnosis, treatment and vaccination. Pharmacological Reports 74:6, pages 1120-1148.
Crossref
Shadma Wahab, Abdulrhman Alsayari, Abdullatif Bin Muhsinah, Dalia Almaghaslah, Anzarul Haque, Mohammad Khalid, Sulaiman Mohammed Alnasser, Faizul Azam & Md. Sarfaraj Hussain. (2022) The Structural, Biological, and In-Silico Profiling of Novel Capryloyl Tetra-Glucoside and Aliphatic Ester Constituents from the Abutilon indicum Offers New Perspectives on the Treatment of Pain and Inflammation. Plants 11:19, pages 2583.
Crossref
Nastaran Barati, Seyedmousa Motavallihaghi, Banafsheh Nikfar, Shahla Chaichian & Amir Abbas Momtazi-Borojeni. (2022) Potential therapeutic effects of Ivermectin in COVID-19. Experimental Biology and Medicine 247:15, pages 1388-1396.
Crossref
Linda M. Mohamed, Maha M. Eltigani, Marwa H. Abdallah, Hiba Ghaboosh, Yousef A. Bin Jardan, Osman Yusuf, Tilal Elsaman, Magdi A. Mohamed & Abdulrahim A. Alzain. (2022) Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies. Frontiers in Chemistry 10.
Crossref
Amena Ali, Abuzer Ali, Musarrat Husain Warsi, Mohammad Akhlaquer Rahman, Mohamed Jawed Ahsan & Faizul Azam. (2022) Toward the Discovery of a Novel Class of Leads for High Altitude Disorders by Virtual Screening and Molecular Dynamics Approaches Targeting Carbonic Anhydrase. International Journal of Molecular Sciences 23:9, pages 5054.
Crossref
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, Somayeh Matin & Soheila Molaei. (2022) Can anti-parasitic drugs help control COVID-19?. Future Virology 17:5, pages 315-339.
Crossref
Océane Delandre, Mathieu Gendrot, Priscilla Jardot, Marion Le Bideau, Manon Boxberger, Céline Boschi, Isabelle Fonta, Joel Mosnier, Sébastien Hutter, Anthony Levasseur, Bernard La Scola & Bruno Pradines. (2022) Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants. Pharmaceuticals 15:4, pages 445.
Crossref
Vaishali M. Patil, Saroj Verma & Neeraj Masand. (2022) Prospective mode of action of Ivermectin: SARS-CoV-2. European Journal of Medicinal Chemistry Reports 4, pages 100018.
Crossref
Faizul Azam, Eltayeb E M Eid & Abdulkarim Almutairi. (2021) Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation. Journal of Molecular Structure 1246, pages 131124.
Crossref
Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, Francelys V. Fernández-Materán, Joan Vera-Villalobos, Marcos Loroño, J.L. Paz, Laura Jeffreys & Ysaias J. Alvarado. (2021) Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach. Biophysical Chemistry 278, pages 106677.
Crossref
Antonio Francés-Monerris, Cristina García-Iriepa, Isabel Iriepa, Cécilia Hognon, Tom Miclot, Giampaolo Barone, Antonio Monari & Marco Marazzi. (2021) Microscopic interactions between ivermectin and key human and viral proteins involved in SARS-CoV-2 infection. Physical Chemistry Chemical Physics 23:40, pages 22957-22971.
Crossref
Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, Francelys V. Fernández-Materán, Joan Vera-Villalobos, Marcos Loroño, J.L. Paz, Laura Jeffreys & Ysaias J. Alvarado. (2021) Structural deformability induced in proteins of potential interest associated with COVID-19 by binding of homologues present in ivermectin: Comparative study based in elastic networks models. Journal of Molecular Liquids 340, pages 117284.
Crossref
Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary, Anurag Maurya, Rakesh Roshan, Faizul Azam, Jyoti Mehta, Shailendra Handu, Ramasare Prasad, Neeraj Jain, Avaneesh Kumar Pandey & Puneet Dhamija. (2021) Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets. Cells 10:9, pages 2427.
Crossref
Faizul Azam. (2021) Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19. Antibiotics 10:7, pages 856.
Crossref
Kamal A. Qureshi, Avinash D. Bholay, Pankaj K. Rai, Hamdoon A. Mohammed, Riaz A. Khan, Faizul Azam, Mariusz Jaremko, Abdul-Hamid Emwas, Piotr Stefanowicz, Mateusz Waliczek, Monika Kijewska, Ehab A. Ragab, Medhat Rehan, Gamal O. Elhassan, Md Jamir Anwar & Dinesh K. Prajapati. (2021) Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23. Scientific Reports 11:1.
Crossref
Aura Rusu, Eliza-Mihaela Arbănaşi, Ioana-Andreea Lungu & Octavia-Laura Moldovan. (2021) Perspectives on Antiviral Drugs Development in the Treatment of COVID-19. Acta Biologica Marisiensis 4:1, pages 44-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.